Leadership Group for a Clinical Research Network on Antibacterial Resistance Program

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, otherwise referred to as NIH, is an agency operating within the United States Department of Health and Human Services that's primarily accountable for ensuring and financially supporting the country's biomedical and health-related research studies.

The grants and initiatives of the NIH are all designed to contribute to the realization of its general agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In line with this mission, the National Institutes of Health has collaborated with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the Leadership Group for a Clinical Research Network on Antibacterial Resistance Program wherein both agencies tend to support the common goal of seeking applications from domestic institutions/organizations expressing their intent to serve as the Leadership Group for a Clinical Research Network on Antibacterial Resistance.

The primary purpose of this inquiry is to create, prioritize, implement, and manage and integrated clinical research program that could potentially lead to the alleviation of antibacterial resistance.

  (continued...)

Leadership Group for a Clinical Research Network on Antibacterial Resistance Program
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on philanthropy giving and community grants.

Additional Resources

category - Health Grants

Small Business Innovation Research Phase IIB Bridge Awards
In line with this mission, the NIH has recently constituted the Small Business Innovation Research Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics Toward Commercialization Program.

---

Funding Opportunity Announcement: Developing Sustainable Healthy Behaviors in Children and Adolescents
The FOA is designed to encourage the use of Exploratory/Developmental Research Grant Awards in employing innovative research studies that would help in determining mechanisms that could promote and influence positive sustainable health behaviors in children and in adolescents, from birth to 18 years old.

---

Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.
The USFA has recently formed a collaboration with the National Institutes of Health to establish the Predictive Lung Deposition Models for Safety and Efficacy of Orally Inhaled Drug Products Program.

---

HIV Innovations for Improved Patient Outcomes for Priority Populations Program
The United States Agency for International Development in South Africa has recently established the HIV Innovations for Improved Patient Outcomes for Priority Populations Program wherein it intends to solicit applications coming from local organizations which are interested in heading the implementation of a five-year plan centered on the program in focus.

---